DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Moreau P, Pylypenko H, Grosicki S. , et al.
Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study.
Lancet Oncol 2011;
12 (05) 431-440
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.